Cabio Biotech (wuhan) Co. Ltd. Class ASSE: 688089

Announcement on Holding the Investors' Briefing on Terminating Major Asset Restructuring

· Issued by Cabio Biotech (wuhan) Co. Ltd. Class A via Shanghai Stock Exchange
Announcement on Holding the Investors' Briefing on Terminating Major Asset Restructuring

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment